Aesther Healthcare Acquisition to Seek 3-Month Extension on Ocean Biomedical Deal

Aesther announced today that its board has approved an extension to Dec. 16 for completion of the SPAC’s merger with Ocean Biomedical, a $345 million deal. In consideration for the extension, the sponsor has agreed to deposit $1.05 million (10 cents a share) into Aesther’s trust account.

The SPAC’s governing documents permit two three-month extensions, of which this is the first.

The SPAC announced a merger agreement with Ocean Biomedical late last month. Aesther raised $105 million in a September 2021 IPO and has secured a $40 million backstop on the Ocean Biomedical deal. Read more.

Total
0
Shares
Related Posts
Read More

Lights Out at 7 Acquisition

7 Acquisition raised $230 million in a November 2021 IPO. The SPAC said in its initial filing with the SEC that it would target companies providing environmental, business and/or infrastructure products and services that will contribute to a more sustainable future.